IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease

Journal of Immunology

Volumn 181, Issue 2, 2008, Pages 1109-1119

  Miyagawa, Fumi ^a   Tagaya, Yutaka ^a   Kim, Brian S ^a,b   Patel, Hiral J ^a,b   Ishida, Kazuto ^c   Ohteki, Toshiaki ^c   Waldmann, Thomas A ^a   Katz, Stephen I ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; INTERLEUKIN 15; T LYMPHOCYTE RECEPTOR; OVALBUMIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; EXPERIMENTAL MOUSE; FUNCTIONAL STATUS; GRAFT VERSUS HOST REACTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DISEASE; TRANSGENIC MOUSE; ANIMAL; AUTOIMMUNITY; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; METABOLISM;

ANIMALS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; INTERLEUKIN-15; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN;

EID: 49049107410     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.2.1109     Document Type: Article

References (41)

1. Kappler, J. W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49: 273-280.
2. + thymocytes. Nature 333: 742-746.
3. Pircher, H., K. Burki, R. Lang, H. Hengartner, and R. M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561. (Pubitemid 20005822)
4. Bouneaud, C., P. Kourilsky, and P. Bousso. 2000. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13: 829-840. (Pubitemid 32041805)
5. Walker, L. S., and A. K. Abbas. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2: 11-19.
6. Rocha, B., and H. von Boehmer. 1991. Peripheral selection of the T cell repertoire. Science 251: 1225-1228.
7. Jones, L. A., L. T. Chin, D. L. Longo, and A. M. Kruisbeek. 1990. Peripheral clonal elimination of functional T cells. Science 250: 1726-1729.
8. Heath, W. R., and F. R. Carbone. 2001. Cross-presentation, dendritic cells, tolerance, and immunity. Annu. Rev. Immunol. 19: 47-64. (Pubitemid 32368029)
9. Ohashi, P. S., and A. L. DeFranco. 2002. Making and breaking tolerance. Curr. Opin. Immunol. 14: 744-759.
10. Liu, K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R. M. Steinman. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196: 1091-1097. (Pubitemid 35231767)
11. Bonifaz, L., D. Bonnyay, K. Mahnke, M. Rivera, M. C. Nussenzweig, and R. M. Steinman. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196: 1627-1638. (Pubitemid 36026474)
12. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779. (Pubitemid 32983013)
13. Scheinecker, C., R. McHugh, E. M. Shevach, and R. N. Germain. 2002. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196: 1079-1090. (Pubitemid 35231766)
14. Kurts, C., R. M. Sutherland, G. Davey, M. Li, A. M. Lew, E. Blanas, F. R. Carbone, J. F. Miller, and W. R. Heath. 1999. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. USA 96: 12703-12707. (Pubitemid 29513566)
15. + T cell tolerance to peripherally expressed antigens. J. Immunol. 163: 723-727.
16. Curtsinger, J. M., D. C. Lins, and M. F. Mescher. 2003. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197: 1141-1151.
17. + T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. J. Invest. Dermatol. 123: 109-115.
18. + T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194: 707-717.
19. + T cells responding to self-antigens. J. Exp. Med. 196: 323-333.
20. + T cells undergoing peripheral tolerance to high-dose self-antigen. Eur. J. Immunol. 34: 1351-1360.
21. + T cells in vivo by IL-15. Immunity 8: 591-599.
22. + memory T cells by opposing cytokines. Science 288: 675-678.
23. Waldmann, T. A., S. Dubois, and Y. Tagaya. 2001. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14: 105-110.
24. Schluns, K. S., K. Williams, A. Ma, X. X. Zheng, and L. Lefrancois. 2002. Cutting edge: Requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168: 4827-4831.
25. Becker, T. C., E. J. Wherry, D. Boone, K. Murali-Krishna, R. Antia, A. Ma, and R. Ahmed. 2002. Interleukin 15 is required for proliferative renewal of virusspecific memory CD8 T cells. J. Exp. Med. 195: 1541-1548.
26. + T cells. J. Exp. Med. 196: 935-946.
27. Kovanen, P. E., and W. J. Leonard. 2004. Cytokines and immunodeficiency diseases: critical roles of the γ(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202: 67-83.
28. Kuwajima, S., T. Sato, K. Ishida, H. Tada, H. Tezuka, and T. Ohteki. 2006. Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat. Immunol. 7: 740-746. (Pubitemid 43905873)
29. Aiba, S., and S. I. Katz. 1990. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunol. 145: 2791-2796. (Pubitemid 20382543)
30. Schluns, K. S., W. C. Kieper, S. C. Jameson, and L. Lefrancois. 2000. Interleukin- 7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.
31. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98: 8732-8737. (Pubitemid 32678096)
32. Fry, T. J., and C. L. Mackall. 2005. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174: 6571-6576.
33. Ohteki, T., K. Suzue, C. Maki, T. Ota, and S. Koyasu. 2001. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol. 2: 1138-1143. (Pubitemid 33130148)
34. Loser, K., A. Mehling, J. Apelt, S. Stander, P. G. Andres, H. C. Reinecker, B. R. Eing, B. V. Skryabin, G. Varga, T. Schwarz, and S. Beissert. 2004. Enhanced contact hypersensitivity and antiviral immune responses in vivo by keratinocyte- targeted overexpression of IL-15. Eur. J. Immunol. 34: 2022-2031. (Pubitemid 39256083)
35. Dubois, S. P., T. A. Waldmann, and J. R. Muller. 2005. Survival adjustment of mature dendritic cells by IL-15. Proc. Natl. Acad. Sci. USA 102: 8662-8667. (Pubitemid 40862792)
36. Dubois, S., J. Mariner, T. A. Waldmann, and Y. Tagaya. 2002. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 17: 537-547. (Pubitemid 35351500)
37. Lodolce, J. P., P. R. Burkett, D. L. Boone, M. Chien, and A. Ma. 2001. T cellindependent interleukin 15Rα signals are required for bystander proliferation. J. Exp. Med. 194: 1187-1194.
38. Lang, K. S., M. Recher, T. Junt, A. A. Navarini, N. L. Harris, S. Freigang, B. Odermatt, C. Conrad, L. M. Ittner, S. Bauer, et al. 2005. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11: 138-145.
39. Rosenberg, S. A., J. C. Yang, S. L. Topalian, D. J. Schwartzentruber, J. S. Weber, D. R. Parkinson, C. A. Seipp, J. H. Einhorn, and D. E. White. 1994. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. J. Am. Med. Assoc. 271: 907-913. (Pubitemid 24083215)
40. + T cells. Proc. Natl. Acad. Sci. USA 101: 15154-15159.
41. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174: 4465-4469. (Pubitemid 40504523)